{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:26:38Z","timestamp":1790403998043,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.taap.2018.11.012","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T16:44:36Z","timestamp":1543423476000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats"],"prefix":"10.1016","volume":"363","author":[{"given":"C.","family":"Behr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Slopianka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Haake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sperber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Walk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Beekmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.M.C.M.","family":"Rietjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"van Ravenzwaay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2018.11.012_bb0005","first-page":"37","article-title":"The dietary effects of sodium carboxymethylcellulose in man","volume":"1","author":"Anderson","year":"1986","journal-title":"Top. Catal."},{"key":"10.1016\/j.taap.2018.11.012_bb0010","doi-asserted-by":"crossref","unstructured":"Arimori, K., Miyamoto, S., Fukuda, K., Nakamura, C., Nakano, M., 1998. Characteristic difference in gastrointestinal excretion of clarithromycin and roxithromycin. Biopharm. Drug Dispos. 19, 433\u2013438. https:\/\/doi.org\/10.1002\/(SICI)1099-081X(199810)19:7<433::AID-BDD122>3.0.CO;2-Z.","DOI":"10.1002\/(SICI)1099-081X(199810)19:7<433::AID-BDD122>3.0.CO;2-Z"},{"key":"10.1016\/j.taap.2018.11.012_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.toxlet.2018.08.002","article-title":"Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces","volume":"296","author":"Behr","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2018.11.012_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2885.1991.tb00801.x","article-title":"Comparative pharmacokinetics of amionoglycoside antibiotics","volume":"14","author":"Brown","year":"1991","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2018.11.012_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00271-10","article-title":"Colonization-Induced Host-Gut Microbial Metabolic Interaction","volume":"2","author":"Claus","year":"2011","journal-title":"MBio"},{"key":"10.1016\/j.taap.2018.11.012_bb0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0009-2797(88)90015-4","article-title":"In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: Comparison with troleandomycin and erythromycin","volume":"68","author":"Delaforge","year":"1988","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2018.11.012_bb0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0031-3955(16)34320-6","article-title":"Erythromycin, lincomycin, and clindamycin","volume":"30","author":"Derrick","year":"1983","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.taap.2018.11.012_bb0040","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/nmo.12829","article-title":"Interplay between bile acid metabolism and microbiota in irritable bowel syndrome","volume":"28","author":"Dior","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.taap.2018.11.012_bb0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","article-title":"Connecting dysbiosis, bile-acid dysmetabolism and Gut inflammation in inflammatory bowel diseases","volume":"62","author":"Duboc","year":"2013","journal-title":"Gut"},{"issue":"181","key":"10.1016\/j.taap.2018.11.012_bb0050","article-title":"Bile acid: a potential inducer of colon cancer stem cells","volume":"7","author":"Farhana","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.taap.2018.11.012_bb0055","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1194\/jlr.D028803","article-title":"Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method","volume":"53","author":"Garc\u00eda-Ca\u00f1averas","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2018.11.012_bb0060","first-page":"90","article-title":"Some laboratory and clinical experiences with a new antibiotic","author":"Geraci","year":"1956","journal-title":"vancomycin. Antibiot Annu."},{"key":"10.1016\/j.taap.2018.11.012_bb0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0041-008X(64)80014-4","article-title":"Animal Toxicity Studies of a New Antibiotic, Lincomycin","volume":"6","author":"Gray","year":"1964","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.11.012_bb0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0041-008X(66)90003-2","article-title":"Further toxicologic studies of lincomycin","volume":"9","author":"Gray","year":"1966","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.11.012_bb0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0041-008X(71)90108-6","article-title":"Ultrastructural studies of the hepatic changes brought about by clindamycin and erythromycin in animals","volume":"19","author":"Gray","year":"1971","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.11.012_bb0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0041-008X(72)90008-7","article-title":"The Oral Toxicity of Clindamycin in Laboratory Animals","volume":"21","author":"Gray","year":"1972","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.11.012_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14814\/phy2.12627","article-title":"Vancomycin treatment and butyrate supplementation modulate gut microbe composition and severity of neointimal hyperplasia after arterial injury","volume":"3","author":"Ho","year":"2015","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.taap.2018.11.012_bb0090","doi-asserted-by":"crossref","unstructured":"Huttenhower, C., Gevers, D., Knight, R., Al., E., 2012. Structure, function and diversity of the healthy human microbiome. Nature 486, 207\u2013214. https:\/\/doi.org\/10.1038\/nature11234","DOI":"10.1038\/nature11234"},{"key":"10.1016\/j.taap.2018.11.012_bb0095","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1194\/jlr.R900007-JLR200","article-title":"Bile acids as regulatory molecules","volume":"50","author":"Hylemon","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2018.11.012_bb0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid\u2013microbiota cross-talk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.taap.2018.11.012_bb0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.toxlet.2012.09.015","article-title":"Reproducibility and robustness of metabolome analysis in rat plasma of 28-day repeated dose toxicity studies","volume":"215","author":"Kamp","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2018.11.012_bb0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1752-8062.2011.00272.x","article-title":"Bile acids regulate cardiovascular function","volume":"4","author":"Khurana","year":"2011","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.taap.2018.11.012_bb0115","first-page":"30","article-title":"Antibiotic-induced elevations of plasma bile acids in rats independent of Bsep inhibition","volume":"157","author":"Li","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2018.11.012_bb0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mam.2017.06.002","article-title":"Interactions between gut bacteria and bile in health and disease","volume":"56","author":"Long","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.taap.2018.11.012_bb0125","series-title":"Vitamin D Receptor as an Intestinal Bile Acid Sensor. Science (80-.)","first-page":"1313","volume":"Vol. 296","author":"Makishima","year":"2002"},{"key":"10.1016\/j.taap.2018.11.012_bb0130","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2018.11.012_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0151829","article-title":"Bile acids and dysbiosis in non-alcoholic fatty liver disease","volume":"11","author":"Mouzaki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2018.11.012_bb0140","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejps.2013.08.018","article-title":"Animal versus human oral drug bioavailability: do they correlate?","volume":"57","author":"Musther","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.taap.2018.11.012_bb0145","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/jgh.13383","article-title":"Short bowel syndrome (SBS)-associated alterations within the gut-liver axis evolve early and persist long-term in the piglet model of short bowel syndrome","volume":"31","author":"Pereira-Fantini","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2018.11.012_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2018.11.012_bb0155","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the Gut Microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.taap.2018.11.012_bb0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1079\/BJN19850038","article-title":"Increase in the ileal absorption rate of sodium taurocholate in germ-free or conventional rats given an amylomaize-starch diet","volume":"53","author":"Riottot","year":"1985","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.taap.2018.11.012_bb0165","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1124\/dmd.115.065276","article-title":"Importance of large Intestine in Regulating Bile Acids and GLP-1 in Germ-free mice","volume":"5","author":"Selwyn","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2018.11.012_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2017.05.009","article-title":"Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in rats","volume":"386","author":"Slopianka","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2018.11.012_bb0175","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/ps\/77.10.1534","article-title":"The Inhibitory effect of Carboxymethylcellulose with High Viscosity on Lipid Absorption in broiler chickens Coincides with Reduced Bile Salt Concentration and Raised Microbial Numbers in the Small Intestine","volume":"77","author":"Smits","year":"1998","journal-title":"Poult. Sci."},{"key":"10.1016\/j.taap.2018.11.012_bb0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.toxlet.2012.03.798","article-title":"Increased toxicity when fibrates and statins are administered in combination - a metabolomics approach with rats","volume":"211","author":"Strauss","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2018.11.012_bb0185","volume":"1","author":"Theriot","year":"2015","journal-title":"Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine. mSphere"},{"key":"10.1016\/j.taap.2018.11.012_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","author":"Thomas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2018.11.012_bb0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.toxlet.2007.05.021","article-title":"The use of metabolomics for the discovery of new biomarkers of effect","volume":"172","author":"van Ravenzwaay","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2018.11.012_bb0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2010.06.009","article-title":"The individual and combined metabolite profiles (metabolomics) of dibutylphthalate and di(2-ethylhexyl)phthalate following a 28-day dietary exposure in rats","volume":"198","author":"van Ravenzwaay","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2018.11.012_bb0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.mrgentox.2012.01.006","article-title":"Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR","volume":"746","author":"van Ravenzwaay","year":"2012","journal-title":"Mutat. Res. - Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.taap.2018.11.012_bb0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1504\/IJBT.2015.074801","article-title":"The development of a database for metabolomics \u2013 looking back on ten years of experience","volume":"14","author":"van Ravenzwaay","year":"2016","journal-title":"Int. J. Biotechnol."},{"key":"10.1016\/j.taap.2018.11.012_bb0215","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","article-title":"The Bile Acid Receptor FXR is a Modulator of Intestinal Innate Immunity","volume":"183","author":"Vavassori","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2018.11.012_bb0220","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1128\/AAC.32.10.1541","article-title":"Toxicity, uptake, and subcellular distribution in rat hepatocytes of roxithromycin, a new semisynthetic macrolide, and erythromycin base","volume":"32","author":"Villa","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2018.11.012_bb9955","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/JOE-15-0469","article-title":"The role of bile acids in metabolic regulation","volume":"228","author":"V\u00edtek","year":"2016","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.taap.2018.11.012_bb0225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/43.suppl_2.91","article-title":"Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone","volume":"43","author":"von Keutz","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.taap.2018.11.012_bb0230","series-title":"WHO FOOD ADDITIVES SERIES 39","author":"World Health Organization","year":"1997"},{"key":"10.1016\/j.taap.2018.11.012_bb0235","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1073\/pnas.051014398","article-title":"An essential role for nuclear receptors SXR\/PXR in detoxification of cholestatic bile acids","volume":"98","author":"Xie","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.taap.2018.11.012_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gastro\/gox031","article-title":"Dysbiosis of gut microbiota in promoting the development of colorectal cancer","volume":"6","author":"Zou","year":"2017","journal-title":"Gastroenterol. Rep."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18305155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18305155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T08:52:18Z","timestamp":1545987138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18305155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":49,"alternative-id":["S0041008X18305155"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.11.012","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}